ALiA BioTech’s One-stop Diagnostic Platform Brings Multiplex Testing to the Medical Front Line
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Diagnostic Technologies |
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Colorectal |
Helio Genomics unveiled positive finds of its multimodal epigenetic sequencing assay (MESA) for colon cancer detection.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
NuraLogix unveiled a platform that performs continuous health and vital sign measurements while on a video telemedicine call.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Disease States |
Twist Bioscience and Centogene N.V. launched three NGS target enrichment panels to support rare disease and hereditary cancer diagnostics.
Read More